The role of inflammation in perinatal brain injury

Nature Reviews Neurology

Volumn 11, Issue 4, 2015, Pages 192-208

  Hagberg, Henrik ^a,b   Mallard, Carina ^b   Ferriero, Donna M ^c   Vannucci, Susan J ^d   Levison, Steven W ^e   Vexler, Zinaida S ^c   Gressens, Pierre ^a,c,f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHEMOKINE; CROMOGLYCATE DISODIUM; CYTOKINE; DEXAMETHASONE; ERYTHROPOIETIN; ETANERCEPT; HISTONE DEACETYLASE INHIBITOR; IMMUNOMODULATING AGENT; INDOMETACIN; INNATE DEFENSE REGULATORY PEPTIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MELATONIN; MINOCYCLINE; NIMESULIDE; PATTERN RECOGNITION RECEPTOR; PIFITHRIN MU; PLACEBO; PRAVASTATIN; PROTECTIVE AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; TIANEPTINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRICHOSTATIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; AUTACOID;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN INJURY; BRAIN ISCHEMIA; CELL MIGRATION; CELL SURVIVAL; CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; CHORIOAMNIONITIS; ENCEPHALOMALACIA; EPIGENETICS; EXCITOTOXICITY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOMODULATION; INDUCED HYPOTHERMIA; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MENTAL DISEASE; MICROGLIA; MYELINATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; OLIGODENDROGLIA; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SYNAPTOGENESIS; ANIMAL; BRAIN; COMPLICATION; ENCEPHALITIS; FEMALE; FETUS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION;

ADAPTIVE IMMUNITY; ANIMALS; BRAIN; BRAIN INJURIES; ENCEPHALITIS; FEMALE; FETUS; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INFLAMMATION MEDIATORS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84926525519     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.13     Document Type: Review

References (188)

1. Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12-18 (2007).
2. Meyer, U., Feldon, J. & Dammann, O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr. Res. 69, 26R-33R (2011).
3. Hagberg, H., Gressens, P. & Mallard, C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann. Neurol. 71, 444-457 (2012).
4. Fernandez-Lopez, D., Natarajan, N., Ashwal, S. & Vexler, Z. S. Mechanisms of perinatal arterial ischemic stroke. J. Cereb. Blood Flow Metab. 34, 921-932 (2014).
5. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
6. Chen, G. Y. & Nunez, G. Sterile inflammation: Sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837 (2010).
7. Stridh, L., Smith, P. L., Naylor, A. S., Wang, X. & Mallard, C. Regulation of Toll-like receptor 1 and 2 in neonatal mice brains after hypoxia-ischemia. J. Neuroinflammation 8, 45 (2011).
8. Stridh, L., Ek, C. J., Wang, X., Nilsson, H. & Mallard, C. Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli. Transl. Stroke Res. 4, 220-227 (2013).
9. Lathia, J. D. et al. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 28, 13978-13984 (2008).
10. Ma, Y. et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175, 209-215 (2006).
11. Vontell, R. et al. Toll-like receptor 3 expression in glia and neurons alters in response to white matter injury in preterm infants. Dev. Neurosci. 35, 130-139 (2013).
12. Smith, P. L., Hagberg, H., Naylor, A. S. & Mallard, C. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev. Neurosci. 36, 119-131 (2014).
13. Cai, Z., Pan, Z. L., Pang, Y., Evans, O. B. & Rhodes, P. G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47, 64-72 (2000).
14. Garay, P. A., Hsiao, E. Y., Patterson, P. H. & McAllister, A. K. Maternal immune activation causes age-and region-specific changes in brain cytokines in offspring throughout development. Brain Behav. Immun. 31, 54-68 (2013).
15. Stolp, H. B. et al. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development. Eur. J. Neurosci. 26, 3465-3474 (2007).
16. Nathan, C. Points of control in inflammation. Nature 420, 846-852 (2002).
17. McRae, A., Gilland, E., Bona, E. & Hagberg, H. Microglia activation after neonatal hypoxic-ischemia. Brain Res. Dev. Brain Res. 84, 245-252 (1995).
18. Jin, Y., Silverman, A. J. & Vannucci, S. J. Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40, 3107-3112 (2009).
19. Palmer, C., Roberts, R. L. & Young, P. I. Timing of neutrophil depletion influences long-term neuroprotection in neonatal rat hypoxic-ischemic brain injury. Pediatr. Res. 55, 549-556 (2004).
20. Bona, E. et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr. Res. 45, 500-509 (1999).
21. Winerdal, M. et al. Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice. PLoS ONE 7, e36422 (2012).
22. Smith, P. L., Ek, J., Hagberg, H. & Mallard, C. Peripheral myeloid cells invade the brain following neonatal hypoxic-ischemic insult. In Proc. 43rd Annual Meeting of the Society for Neuroscience 813. 10 (2013).
23. Fernandez-Lopez, D. et al. Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. J. Neurosci. 32, 9588-9600 (2012).
24. Ek, J. C. et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J. Cereb Blood Flow Metab. http://dx. doi. org/10. 1038/jcbfm. 2014. 255.
25. Kichev, A. et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation. J. Biol. Chem. 289, 9430-9439 (2014).
26. Wang, X. et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J. Immunol. 183, 7471-7477 (2009).
27. Stridh, L. et al. Toll-like receptor3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. J. Neurosci. 33, 12041-12051 (2013).
28. Hagberg, H. et al. Enhanced expression of interleukin (IL)1 and IL6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res. 40, 603-609 (1996).
29. Girard, S. et al. Postnatal administration of IL1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav. Immun. 26, 1331-1339 (2012).
30. Liu, X. H. et al. Mice deficient in interleukin1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J. Cereb. Blood Flow Metab. 19, 1099-1108 (1999).
31. Hedtjarn, M. et al. Interleukin18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22, 5910-5919 (2002).
32. Doverhag, C. et al. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol. Dis. 31, 133-144 (2008).
33. Denker, S. P. et al. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J. Neurochem. 100, 893-904 (2007).
34. Arvin, K. L. et al. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52, 54-61 (2002).
35. Faustino, J. V. et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J. Neurosci. 31, 12992-13001 (2011).
36. Woo, M. S. et al. Genetic deletion of CD36 enhances injury after acute neonatal stroke. Ann. Neurol. 72, 961-970 (2012).
37. Colton, C. & Wilcock, D. M. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9, 174-191 (2010).
38. Chhor, V. et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70-85 (2013).
39. Lindsberg, P. J., Strbian, D. & Karjalainen-Lindsberg, M. L. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 30, 689-702 (2010).
40. Nelissen, S. et al. The role of mast cells in neuroinflammation. Acta Neuropathol. 125, 637-650 (2013).
41. Mesples, B., Fontaine, R. H., Lelievre, V., Launay, J. M. & Gressens, P. Neuronal TGF-1 mediates IL9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol. Dis. 18, 193-205 (2005).
42. Jin, Y., Silverman, A. J. & Vannucci, S. J. Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev. Neurosci. 29, 373-384 (2007).
43. Biran, V. et al. Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain. Brain Pathol. 18, 1-9 (2008).
44. Schwartz, M. & Baruch, K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 33, 7-22 (2014).
45. Shechter, R., London, A. & Schwartz, M. Orchestrated leukocyte recruitment to immune-privileged sites: Absolute barriers versus educational gates. Nat. Rev. Immunol. 13, 206-218 (2013).
46. Hurn, P. D. et al. T and Bcelldeficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 1798-1805 (2007).
47. Iadecola, C. & Anrather, J. The immunology of stroke: From mechanisms to translation. Nat. Med. 17, 796-808 (2011).
48. Ellestad, K. K. et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J. Immunol. 183, 298-309 (2009).
49. Li, X. L. et al. Neonatal endotoxin exposure suppresses experimental autoimmune encephalomyelitis through regulating the immune cells responsivity in the central nervous system of adult rats. Biochem. Biophys. Res. Commun. 398, 302-308 (2010).
50. Mandal, M., Marzouk, A. C., Donnelly, R. & Ponzio, N. M. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 25, 863-871 (2011).
51. Horiuchi, M., Itoh, A., Pleasure, D. & Itoh, T. MEK-ERK signaling is involved in interferon-induced death of oligodendroglial progenitor cells. J. Biol. Chem. 281, 20095-20106 (2006).
52. Eklind, S. et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 13, 1101-1106 (2001).
53. Lehnardt, S. et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478-2486 (2002).
54. Kendall, G. S. et al. TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Lab. Invest. 91, 328-341 (2011).
55. Yang, D. et al. Intranasal delivery of cell-penetrating antiNF-B peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp. Neurol. 247, 447-455 (2013).
56. Grether, J. K. & Nelson, K. B. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 278, 207-211 (1997).
57. Sävman, K., Blennow, M., Gustafson, K., Tarkowski, E. & Hagberg, H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr. Res. 43, 746-751(1998).
58. Bartha, A. I. et al. Neonatal encephalopathy: Association of cytokines with MR spectroscopy and outcome. Pediatr. Res. 56, 960-966 (2004).
59. Nelson, K. B., Dambrosia, J. M., Grether, J. K. & Phillips, T. M. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann. Neurol. 44, 665-675 (1998).
60. Lassiter, H. A., Watson, S. W., Seifring, M. L. & Tanner, J. E. Complement factor 9 deficiency in serum of human neonates. J. Infect. Dis. 166, 53-57 (1992).
61. Wu, Y. W. et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290, 2677-2684 (2003).
62. Jenster, M. et al. Maternal or neonatal infection: Association with neonatal encephalopathy outcomes. Pediatr. Res. 76, 93-99 (2014).
63. Eklind, S., Mallard, C., Arvidsson, P. & Hagberg, H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr. Res. 58, 112-116 (2005).
64. Armstrong-Wells, J. et al. Inflammatory predictors of neurologic disability after preterm premature rupture of membranes. Am. J. Obstet. Gynecol. http://dx. doi. org/10. 1016/j. ajog. 2014. 09. 016.
65. Nakamura, T., Yamada, S. & Yoshioka, T. Brain hypothermic therapy dramatically decreases elevated blood concentrations of high mobility group box 1 in neonates with hypoxic-ischemic encephalopathy. Dis. Markers 35, 327-330 (2013).
66. Chalak, L. F. et al. Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J. Pediatr. 164, 468-474. e1 (2014).
67. Jenkins, D. D. et al. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy. Pediatr. Crit. Care Med. 14, 786-795 (2013).
68. Gelfand, A. A., Croen, L. A., Torres, A. R. & Wu, Y. W. Genetic risk factors for perinatal arterial ischemic stroke. Pediatr. Neurol. 48, 36-41 (2013).
69. Miller, S. P. et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke 37, 2678-2683 (2006).
70. Lee, J. et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 293, 723-729 (2005).
71. Harteman, J. C. et al. Risk factors for perinatal arterial ischaemic stroke in full-term infants: A case-control study. Arch. Dis. Child. Fetal Neonatal Ed. 97, F411-F416 (2012).
72. Nijboer, C. H. et al. Gender-specific neuroprotection by 2iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J. Cereb. Blood Flow Metab. 27, 282-292 (2007).
73. Boksa, P. Effects of prenatal infection on brain development and behavior: A review of findings from animal models. Brain Behav. Immun. 24, 881-897 (2010).
74. Tahraoui, S. L. et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol. 11, 56-71 (2001).
75. Mallard, C., Welin, A. K., Peebles, D., Hagberg, H. & Kjellmer, I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem. Res. 28, 215-223 (2003).
76. Rousset, C. I. et al. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr. Res. 59, 428-433 (2006).
77. Favrais, G. et al. Systemic inflammation disrupts the developmental program of white matter. Ann. Neurol. 70, 550-565 (2011).
78. Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E. & Heuschling, P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-. J. Neuroimmunol 210, 3-12 (2009).
79. Hu, X. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063-3070 (2012).
80. Wang, G. et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J. Cereb. Blood Flow Metab. 33, 1864-1874 (2013).
81. Miron, V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211-1218 (2013).
82. Plane, J. M., Liu, R., Wang, T. W., Silverstein, F. S. & Parent, J. M. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol. Dis. 16, 585-595 (2004).
83. Yang, Z. et al. Sustained neocortical neurogenesis after neonatal hypoxic/ischemic injury. Ann. Neurol. 61, 199-208 (2007).
84. Covey, M. V., Loporchio, D., Buono, K. D. & Levison, S. W. Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury. Ann. Neurol. 70, 616-626 (2011).
85. Covey, M. V. & Levison, S. W. Leukemia inhibitory factor participates in the expansion of neural stem/progenitors after perinatal hypoxia/ischemia. Neuroscience 148, 501-509 (2007).
86. Back, S. A. et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302-1312 (2001).
87. Haynes, R. L. et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J. Neuropathol. Exp. Neurol. 62, 441-450 (2003).
88. Billiards, S. S. et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 18, 153-163 (2008).
89. Dean, J. M. et al. Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann. Neurol. 70, 846-856 (2011).
90. Chang, K. H., Yeh, C. M., Yeh, C. Y., Huang, C. C. & Hsu, K. S. Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury. Mol. Brain 6, 18 (2013).
91. Favrais, G., Schwendimann, L., Gressens, P. & Lelievre, V. Cyclooxygenase2 mediates the sensitizing effects of systemic IL1beta on excitotoxic brain lesions in newborn mice. Neurobiol. Dis. 25, 496-505 (2007).
92. Barger, S. W., Goodwin, M. E., Porter, M. M. & Beggs, M. L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 1205-1213 (2007).
93. Ozawa, H., Nishida, A., Mito, T. & Takashima, S. Immunohistochemical study of ferritin-positive cells in the cerebellar cortex with subarachnoidal hemorrhage in neonates. Brain Res. 651, 345-348 (1994).
94. Folkerth, R. D. et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J. Neuropathol. Exp. Neurol. 63, 990-999 (2004).
95. Follett, P. L., Rosenberg, P. A., Volpe, J. J. & Jensen, F. E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci. 20, 9235-9241 (2000).
96. Ness, J. K., Romanko, M. J., Rothstein, R. P., Wood, T. L. & Levison, S. W. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev. Neurosci. 23, 203-208 (2001).
97. Talos, D. M. et al. Developmental regulation of-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J. Comp. Neurol. 497, 61-77 (2006).
98. Ness, J. K., Scaduto, R. C. Jr & Wood, T. L. IGFI prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia 46, 183-194 (2004).
99. Simonishvili, S., Jain, M. R., Li, H., Levison, S. W. & Wood, T. L. Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia. ASN Neuro 5, e00131 (2013).
100. Deguchi, K., Oguchi, K. & Takashima, S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr. Neurol. 16, 296-300 (1997).
101. Arnett, H. A. et al. TNF? promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4, 1116-1122 (2001).
102. Cammer, W. & Zhang, H. Maturation of oligodendrocytes is more sensitive to TNF? than is survival of precursors and immature oligodendrocytes. J. Neuroimmunol. 97, 37-42 (1999).
103. Pang, Y., Zheng, B., Fan, L. W., Rhodes, P. G. & Cai, Z. IGF1 protects oligodendrocyte progenitors against TNF-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia 55, 1099-1107 (2007).
104. Valerio, A. et al. Soluble interleukin6 (IL6) receptor/IL6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol. Cell Neurosci. 21, 602-615 (2002).
105. Campbell, I. L. et al. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry 2, 125-129 (1997).
106. Xu, G. et al. Late development of the GABAergic system in the human cerebral cortex and white matter. J. Neuropathol. Exp. Neurol. 70, 841-858 (2011).
107. Leviton, A. & Gressens, P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 30, 473-478 (2007).
108. Stewart, W. B., Ment, L. R. & Schwartz, M. Chronic postnatal hypoxia increases the numbers of cortical neurons. Brain Res. 760, 17-21 (1997).
109. Curristin, S. M. et al. Disrupted synaptic development in the hypoxic newborn brain. Proc. Natl Acad. Sci. USA 99, 15729-15734 (2002).
110. Bhalala, O. G., Srikanth, M. & Kessler, J. A. The emerging roles of microRNAs in CNS injuries. Nat. Rev. Neurol. 9, 328-339 (2013).
111. Ozanne, S. E. & Constancia, M. Mechanisms of disease: The developmental origins of disease and the role of the epigenotype. Nat. Clin. Pract. Endocrinol. Metab. 3, 539-546 (2007).
112. Fleiss, B. & Gressens, P. Tertiary mechanisms of brain damage: A new hope for treatment of cerebral palsy? Lancet Neurol. 11, 556-566 (2012).
113. Schlapbach, L. J. et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 128, e348-e357 (2011).
114. Chau, V., McFadden, D. E., Poskitt, K. J. & Miller, S. P. Chorioamnionitis in the pathogenesis of brain injury in preterm infants. Clin. Perinatol 41, 83-103 (2014).
115. Wu, Y. W. & Colford, J. M. Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 284, 1417-1424 (2000).
116. Shatrov, J. G. et al. Chorioamnionitis and cerebral palsy: A meta-analysis. Obstet. Gynecol. 116, 387-392 (2010).
117. Dammann, O. & Leviton, A. Intermittent or sustained systemic inflammation and the preterm brain. Pediatr. Res. 75, 376-380 (2014).
118. Lin, C. Y. et al. Altered inflammatory responses in preterm children with cerebral palsy. Ann. Neurol. 68, 204-212 (2010).
119. Ohls, R. K. et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics 133, 1023-1030 (2014).
120. Leuchter, R. H. et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA 312, 817-824 (2014).
121. Azzopardi, D. et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr. Res. 25, 445-451 (1989).
122. Vexler, Z. S. & Yenari, M. A. Does inflammation after stroke affect the developing brain differently than adult brain? Dev. Neurosci. 31, 378-393 (2009).
123. Volpe, J. J. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8, 110-124 (2009).
124. Dammann, O. & Leviton, A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 42, 1-8 (1997).
125. Taniguchi, H., Anacker, C., Wang, Q. & Andreasson, K. Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy. Exp. Neurol. 255, 30-37 (2014).
126. Yang, D. et al. Plasminogen activator inhibitor1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia. Cereb. Cortex 23, 1218-1229 (2013).
127. Wang, L. W., Tu, Y. F., Huang, C. C. & Ho, C. J. JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain. J. Neuroinflammation 9, 175 (2012).
128. Du, X. et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS ONE 6, e19583 (2011).
129. Cameron, J. S. et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 27, 13033-13041 (2007).
130. Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I. & Feldon, J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav. Immun. 22, 469-486 (2008).
131. Ratnayake, U., Quinn, T. A., Castillo-Melendez, M., Dickinson, H. & Walker, D. W. Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic Poly I:C at mid-pregnancy. Brain Behav. Immun. 26, 1288-1299 (2012).
132. Ling, Z. et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 17, 116-124 (2002).
133. Duncan, J. R. et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr. Res. 52, 941-949 (2002).
134. Baharnoori, M., Brake, W. G. & Srivastava, L. K. Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats. Schizophr. Res. 107, 99-109 (2009).
135. Wang, X. et al. White matter damage after chronic subclinical inflammation in newborn mice. J. Child Neurol. 24, 1171-1178 (2009).
136. Kannan, S. et al. Decreased cortical serotonin in neonatal rabbits exposed to endotoxin in utero. J. Cereb. Blood Flow Metab. 31, 738-749 (2011).
137. Oskvig, D. B., Elkahloun, A. G., Johnson, K. R., Phillips, T. M. & Herkenham, M. Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav. Immun. 26, 623-634 (2012).
138. Adler, D. A. et al. Circadian cycle-dependent EEG biomarkers of pathogenicity in adult mice following prenatal exposure to in utero inflammation. Neuroscience 275, 305-313 (2014).
139. Feng, Y., Rhodes, P. G. & Bhatt, A. J. Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. Neuroscience 179, 223-232 (2011).
140. Tuor, U. I., Simone, C. S., Barks, J. D. & Post, M. Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke 24, 452-457 (1993).
141. Felszeghy, K., Banisadr, G., Rostene, W., Nyakas, C. & Haour, F. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11, 404-413 (2004).
142. Tsuji, M., Wilson, M. A., Lange, M. S. & Johnston, M. V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189, 58-65 (2004).
143. Dommergues, M. A., Plaisant, F., Verney, C. & Gressens, P. Early microglial activation following neonatal excitotoxic brain damage in mice: A potential target for neuroprotection. Neuroscience 121, 619-628 (2003).
144. Fan, L. W., Pang, Y., Lin, S., Rhodes, P. G. & Cai, Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133, 159-168 (2005).
145. Schmitz, T. et al. Minocycline protects the immature white matter against hyperoxia. Exp. Neurol. 254, 153-165 (2014).
146. Husson, I. et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann. Neurol. 51, 82-92 (2002).
147. Villapol, S. et al. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke. Pediatr. Res. 69, 51-55 (2011).
148. Olivier, P. et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS ONE 4, e7128 (2009).
149. Welin, A. K. et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 61, 153-158 (2007).
150. Yawno, T. et al. Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev. Neurosci. 34, 543-551 (2012).
151. Robertson, N. J. et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 136, 90-105 (2013).
152. van de Looij, Y. et al. Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. PLoS ONE 9, e95643 (2014).
153. Fang, A. Y., Gonzalez, F. F., Sheldon, R. A. & Ferriero, D. M. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia. Pediatr. Res. 73, 12-17 (2013).
154. Gonzalez, F. F. et al. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke 44, 753-758 (2013).
155. Keller, M. et al. Erythropoietin is neuroprotective against NMDAreceptormediated excitotoxic brain injury in newborn mice. Neurobiol. Dis. 24, 357-366 (2006).
156. Traudt, C. M. et al. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev. Neurosci. 35, 491-503 (2013).
157. Plaisant, F. et al. Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 44, 801-809 (2003).
158. Nijboer, C. H. et al. Targeting the p53 pathway to protect the neonatal ischemic brain. Ann. Neurol. 70, 255-264 (2011).
159. Bolouri, H. et al. Innate defense regulator peptide 1018 protects against perinatal brain injury. Ann. Neurol. 75, 395-410 (2014).
160. Lante, F. et al. Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic. Biol. Med. 42, 1231-1245 (2007).
161. Liu, J. Q., Lee, T. F., Chen, C., Bagim, D. L. & Cheung, P. Y. Nacetylcysteine improves hemodynamics and reduces oxidative stress in the brains of newborn piglets with hypoxia-reoxygenation injury. J. Neurotrauma 27, 1865-1873 (2010).
162. Jatana, M., Singh, I., Singh, A. K. & Jenkins, D. Combination of systemic hypothermia and Nacetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 59, 684-689 (2006).
163. Kannan, S. et al. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci. Transl. Med. 18, 130ra46 (2012).
164. Nijboer, C. H., Heijnen, C. J., Groenendaal, F., van Bel, F. & Kavelaars, A. Alternate pathways preserve tumor necrosis factor-production after nuclear factor-B inhibition in neonatal cerebral hypoxia-ischemia. Stroke 40, 3362-3368 (2009).
165. Aden, U. et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNF? pathway and protection by etanercept. Brain Behav. Immun. 24, 747-758 (2010).
166. Pang, Y., Cai, Z. & Rhodes, P. G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 140, 205-214 (2003).
167. Hu, X. et al. Activation of nuclear factor-B signaling pathway by interleukin1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J. Neurochem. 93, 26-37 (2005).
168. Nijboer, C. H. et al. Strong neuroprotection by inhibition of NF-B after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 39, 2129-2137 (2008).
169. Yang, D., et al. Intranasal delivery of cell-penetrating anti-NF-B peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp. Neurol. 247, 447-455 (2013).
170. Balduini, W., De Angelis, V., Mazzoni, E. & Cimino, M. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury. Stroke 32, 2185-2191 (2001).
171. Li, A. et al. Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in neonatal rats. Neurol. Res. 32, 945-952 (2010).
172. Pedroni, S. M. et al. Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth. Biochim. Biophys. Acta 1842, 107-115 (2014).
173. Sandner, G. et al. The HDAC inhibitor phenylbutyrate reverses effects of neonatal ventral hippocampal lesion in rats. Front. Psychiatry 1, 153 (2011).
174. Fleiss, B., Nilsson, M. K., Blomgren, K. & Mallard, C. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. J. Neuroinflammation 9, 70 (2012).
175. George, S. et al. Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice. Front. Cell Neurosci. 7, 123 (2013).
176. McPherson, C. A., Aoyama, M. & Harry, G. J. Interleukin (IL)1 and IL6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain. Brain Behav. Immun. 25, 850-862 (2011).
177. Kokovay, E. et al. VCAM1 is essential to maintain the structure of the SVZ niche and acts as an environmental sensor to regulate SVZ lineage progression. Cell Stem Cell 11, 220-230 (2012).
178. Green, H. F. et al. A role for interleukin-1 in determining the lineage fate of embryonic rat hippocampal neural precursor cells. Mol. Cell. Neurosci. 49, 311-321 (2012).
179. Iosif, R. E. et al. Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J. Cereb. Blood Flow Metab. 28, 1574-1587 (2008).
180. Iosif, R. E. et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 26, 9703-9712 (2006).
181. Monje, M. L., Toda, H. & Palmer, T. D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765 (2003).
182. Calvo, C. F. et al. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev. 25, 831-844 (2011).
183. Bain, J. M., Moore, L., Ren, Z., Simonishvili, S. & Levison, S. W. Vascular endothelial growth factors A and C are induced in the SVZ following neonatal hypoxia-ischemia and exert different effects on neonatal glial progenitors. Transl. Stroke Res. 4, 158-170 (2013).
184. Li, L., Walker, T. L., Zhang, Y., Mackay, E. W. & Bartlett, P. F. Endogenous interferon directly regulates neural precursors in the non-inflammatory brain. J. Neurosci. 30, 9038-9050 (2010).
185. Cheng, A., Wang, S., Cai, J., Rao, M. S. & Mattson, M. P. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev. Biol. 258, 319-333 (2003).
186. Zhu, D. Y., Liu, S. H., Sun, H. S. & Lu, Y. M. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J. Neurosci. 23, 223-229 (2003).
187. Ma, M. et al. Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone. BMC Neurosci. 9, 117 (2008).
188. He, Y. et al. ALK5-dependent TGF-signaling is a major determinant of late-stage adult neurogenesis. Nat. Neurosci. 17, 943-952 (2014).